Home › Waldenstrom Macroglobulinemia › Florida › Miami
Waldenstrom Macroglobulinemia clinical trials in Miami, FL
3 studies for Waldenstrom Macroglobulinemia are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
RecruitingPhase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- University of Miami, Miami
Waldenstrom Macroglobulinemia trials in other cities
- Durham, NC10 studies
- Boston, MA9 studies
- Denver, CO7 studies
- Dallas, TX6 studies
- Edison, NJ6 studies
- Rochester, MN6 studies
- Houston, TX6 studies
- Seattle, WA5 studies
- Milwaukee, WI5 studies
- New York City, NY5 studies
- Columbus, OH4 studies
- Washington, DC4 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer35 studies
- Prostate Cancer30 studies
- Obesity28 studies
- Ovarian Cancer24 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Metastatic Cancer22 studies
- Multiple Myeloma22 studies
- Lung Cancer22 studies
- Alzheimer's Disease21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.